Sign In
Buy QGEN
$41.40
-0.0500 (-0.121%)
At Close: Jul 31, 2026
QIAGEN Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content
04:05pm, Tuesday, 07'th Jan 2025
REDWOOD CITY, Calif. & VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has partnered with Genomics England to support the delivery o
New Product Offerings Support QIAGEN's Shares Amid Currency Woes
11:51am, Monday, 30'th Dec 2024
To support internal growth, QIAGEN is investing heavily in R&D for menu expansion of its key platforms.
Here's Why Qiagen (QGEN) is a Strong Momentum Stock
10:51am, Monday, 30'th Dec 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term
10:56am, Friday, 13'th Dec 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
QIAGEN Stock Gains Following the Latest Launch of IPA Interpret
09:06am, Friday, 13'th Dec 2024
QGEN announces the launch of IPA Interpret to extend the analysis capabilities of a human-curated knowledge base with AI technology.
QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data
04:05pm, Thursday, 12'th Dec 2024
REDWOOD CITY, Calif. & VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN, Frankfurt Prime Standard: QIA) today announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new featu
QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements
09:15am, Monday, 09'th Dec 2024
QGEN achieves milestone with more than 1,000 EZ2 Connect placements worldwide, contributing to a global installed base of over 5,500 EZ series instruments.
QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation
04:05pm, Thursday, 05'th Dec 2024
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has reached a significant milestone with over 1,000 placements of the EZ2 C
Should You Continue to Retain QIAGEN Stock in Your Portfolio Now?
08:50am, Thursday, 05'th Dec 2024
QGEN's robust expansion of its testing menu and potential in molecular diagnostics bode well for investors.
Here's Why Qiagen (QGEN) is a Strong Value Stock
10:40am, Friday, 29'th Nov 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
QGEN Stock to Gain From Expanding QIAstat-Dx With New Barcelona Site
08:41am, Friday, 29'th Nov 2024
QIAGEN's new Barcelona site is set to drive QIAstat-Dx's growth in infectious diseases and precision medicine testing.
QGEN Stock Dips Despite Launch of Customized dPCR Assay Design Tools
08:45am, Thursday, 28'th Nov 2024
QIAGEN introduces two new customizable dPCR assay design tools featuring advanced design algorithms tailored for diverse microbial applications and custom NGS panels.
QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing
06:00am, Thursday, 28'th Nov 2024
BARCELONA, Spain & VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to move its QIAstat-Dx operations within the Barcelona area to a ne
QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis
04:05pm, Wednesday, 27'th Nov 2024
QIAGEN introduces market's first customizable digital PCR assay design tool with advanced design algorithms tailored for diverse microbial applications and custom NGS panels // First-of-its-kind Custo
Here's Why Qiagen (QGEN) is a Strong Momentum Stock
10:56am, Monday, 25'th Nov 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
